What is happening at Global Labeling Conference

• Hot Topic Panel: How companies are addressing labeling challenges in 2020 – from implementation monitoring to audit trends to improvements for the future
• Regulatory updates with health agencies from the major global regions: EU, Japan, US and Canada; Expert perspectives on regulation in other global regions such as wider Asia, Latin America, Australia, and Africa
• Dialog and opportunities to engage on topics such as e-labeling, patient labeling and patient perspectives, use of RWE, and their impact on labeling process

Featured Topics

• Digital Health and the Future of Global Labeling
• Current landscape of e-labeling initiatives across regions including the European Union (EU), Japan, Canada, and Singapore
• Creation of label content generated from patient input, Real World Evidence (RWE), and/or Real World Data RWD
• Emerging labeling markets and managing globally: Reference label, patient labeling, and beyond the label information
• Benefits of early labeling strategies, including the best areas of the label to leverage for market differentiation
• End-to-end tracking, contemporary approaches to governance, and future improvements for compliance
• EU GVP modules and impact on labeling processes
• Labeling for drug-device combinations, including digital apps as devices: Regulations and guidance
• Global Labeling regulatory and policy updates, including developments from the United States (US), EU, Health Canada, Japan, Asia, Australia, Latin America, and Africa
• Impact of Brexit on labeling initiatives
• Japan’s new labeling regulations and the Pharmaceuticals and Medical Devices Agency (PMDA) initiatives in Asia
• Labeling strategies for compliance across Latin America